MEDISTIM ASA NK -,25MEDISTIM ASA NK -,25MEDISTIM ASA NK -,25

MEDISTIM ASA NK -,25

No trades
See on Supercharts
Market capitalization
‪276.35 M‬EUR
‪9.23 M‬EUR
‪46.35 M‬EUR
‪15.47 M‬
Beta (1Y)
0.10

About MEDISTIM ASA NK -,25

CEO
Kari Eian Krogstad
Headquarters
Oslo
Employees (FY)
150
Founded
1984
ISIN
NO0010159684
FIGI
BBG00N8TXLL1
Medistim ASA engages in the development, manufacture, and distribution of medical equipment and consumables. It operates through the Own Products and Third Party Products segments. The Own Products segment leases and sells equipment. The Third Party Products segment markets medical devices purchased from third party manufacturers located in Denmark and Norway. Its products include MiraQ Cardiac, MiraQ Vascular, MiraQ Ultimate, Imaging Probe, and Flow Probe. The company was founded by Kari Mette Tjolsen Pah on June 10, 1984 and is headquartered in Oslo, Norway.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange MEDISTIM ASA NK -,25 stocks are traded under the ticker MD1.
MEDISTIM ASA NK -,25 is going to release the next earnings report on Apr 25, 2024. Keep track of upcoming events with our Earnings Calendar.
MD1 earnings for the last quarter are 0.13 EUR per share, whereas the estimation was 0.13 EUR resulting in a −5.43% surprise. The estimated earnings for the next quarter are 0.13 EUR per share. See more details about MEDISTIM ASA NK -,25 earnings.
MEDISTIM ASA NK -,25 revenue for the last quarter amounts to ‪10.96 M‬ EUR despite the estimated figure of ‪12.14 M‬ EUR. In the next quarter revenue is expected to reach ‪11.65 M‬ EUR.
Yes, you can track MEDISTIM ASA NK -,25 financials in yearly and quarterly reports right on TradingView.
MD1 net income for the last quarter is ‪1.70 M‬ EUR, while the quarter before that showed ‪2.31 M‬ EUR of net income which accounts for −26.40% change. Track more MEDISTIM ASA NK -,25 financial stats to get the full picture.
Yes, MD1 dividends are paid annually. The last dividend per share was 0.38 EUR. As of today, Dividend Yield (TTM)% is 2.41%. Tracking MEDISTIM ASA NK -,25 dividends might help you take more informed decisions.
MEDISTIM ASA NK -,25 dividend yield was 2.10% in 2023, and payout ratio reached 79.18%. The year before the numbers were 1.95% and 72.05% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, MD1 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MEDISTIM ASA NK -,25 stock right from TradingView charts — choose your broker and connect to your account.
MD1 reached its all-time high on Oct 15, 2021 with the price of 39.45 EUR, and its all-time low was 6.65 EUR and was reached on Feb 11, 2019.
See other stocks reaching their highest and lowest prices.
As of Apr 25, 2024, the company has 150.00 employees. See our rating of the largest employees — is MEDISTIM ASA NK -,25 on this list?
We've gathered analysts' opinions on MEDISTIM ASA NK -,25 future price: according to them, MD1 price has a max estimate of 18.28 EUR and a min estimate of 15.23 EUR. Read a more detailed MEDISTIM ASA NK -,25 forecast: see what analysts think of MEDISTIM ASA NK -,25 and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MEDISTIM ASA NK -,25 EBITDA is ‪13.80 M‬ EUR, and current EBITDA margin is 28.76%. See more stats in MEDISTIM ASA NK -,25 financial statements.